Find out what’s new and what this means for your practice.
Mitchell D. Creinin, MD
Advertisement
DR. CREININ is a Professor, Director of Gynecologic Specialties, and Director of Family Planning, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee-Womens Research Institute and Professor
Articles by Mitchell D. Creinin, MD
Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
Clinicians need to stay up-to-date with medication and access issues.
Liletta is under study in a prospective phase 3 clinical trial aimed at extending the approved duration of this levonorgestrel 52-mg IUS.
Advertisement
Latest Updated Articles
Liletta IUS: not just for long-term contraceptionPublished: May 14th 2020 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ayesha Dholakia, MD, discusses firearms as leading cause of US maternal death
2
Sex toy use linked to orgasm frequency in women over 60
3
Paracetamol use in pregnancy not clearly linked to autism or ADHD
4
Major gaps found in endometriosis policies worldwide
5
